Riluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model.

Bezard, E; Stutzmann, J M; Imbert, C; Boraud, T; Boireau, A; Gross, C E

Bezard, E; Stutzmann, J M; Imbert, C; Boraud, T; Boireau, A; Gross, C E.

Affiliation

Bezard E; Laboratoire de Neurophysiologie, CNRS UMR 5543, Université de Bordeaux II, France.

Eur J Pharmacol ; 356(2-3): 101-4, 1998 Sep 04.

Article in En | MEDLINE | ID: mdl-9774238

Subject(s)

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/antagonists & inhibitors; Anticonvulsants/therapeutic use; Parkinson Disease, Secondary/prevention & control; Riluzole/therapeutic use; Sodium Channel Blockers; Animals; Anticonvulsants/administration & dosage; Behavior, Animal/drug effects; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Injections, Intravenous; Macaca fascicularis; Male; Motor Activity/drug effects; Parkinson Disease, Secondary/chemically induced; Riluzole/administration & dosage

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Parkinson Disease, Secondary / 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Riluzole / Sodium Channel Blockers / Anticonvulsants Limits: Animals Language: En Year: 1998 Type: Article

Search on Google

XML

PubMed Links